Page last updated: 2024-08-23

substance p and Prurigo

substance p has been researched along with Prurigo in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Belzberg, M; Huang, AH; Kwatra, SG; Williams, KA1
Eirefelt, S; Hawro, T; Hoey, G; Koopmann, W; Maurer, M; Metz, M; Ohanyan, T; Schoepke, N1
Böhm, M; Capellino, S; Haas, S; Luger, TA; Phan, NQ; Ständer, S; Straub, RH1
Abadia-Molina, F; Burrows, NP; Munn, SE; Polak, JM; Russell Jones, R; Springall, DR1
Luger, T; Metze, D; Ständer, S1
Rechardt, L; Suomalainen, H; Vaalasti, A1

Reviews

1 review(s) available for substance p and Prurigo

ArticleYear
Prurigo nodularis: Pathogenesis and management.
    Journal of the American Academy of Dermatology, 2020, Volume: 83, Issue:6

    Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents; Antipruritics; Biopsy; Calcitonin Gene-Related Peptide; Chronic Disease; Diagnosis, Differential; Humans; Immunosuppressive Agents; Medical History Taking; Nerve Tissue Proteins; Neural Pathways; Phototherapy; Prurigo; Randomized Controlled Trials as Topic; Receptors, Nerve Growth Factor; Severity of Illness Index; Skin; Substance P; Therapies, Investigational; Treatment Outcome

2020

Trials

3 trial(s) available for substance p and Prurigo

ArticleYear
Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.
    Acta dermato-venereologica, 2018, Jan-12, Volume: 98, Issue:1

    Topics: Administration, Cutaneous; Aged; Aprepitant; Case-Control Studies; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Morpholines; Neurokinin-1 Receptor Antagonists; Proof of Concept Study; Prospective Studies; Prurigo; Pruritus; Receptors, Neurokinin-1; Severity of Illness Index; Substance P; Visual Analog Scale

2018
The effect of topical capsaicin on substance P immunoreactivity: a clinical trial and immunohistochemical analysis.
    Acta dermato-venereologica, 1997, Volume: 77, Issue:2

    Topics: Administration, Topical; Capsaicin; Dose-Response Relationship, Drug; Double-Blind Method; Fluorescent Antibody Technique, Indirect; Humans; Prurigo; Substance P; Treatment Outcome

1997
Treatment of prurigo nodularis with topical capsaicin.
    Journal of the American Academy of Dermatology, 2001, Volume: 44, Issue:3

    Topics: Administration, Topical; Adult; Aged; Biopsy; Capsaicin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Prurigo; Pruritus; Substance P; Treatment Outcome

2001

Other Studies

2 other study(ies) available for substance p and Prurigo

ArticleYear
Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis.
    Journal of dermatological science, 2010, Volume: 58, Issue:3

    Topics: Adrenergic Fibers; Adult; Aged; Aged, 80 and over; Biopsy; Chronic Disease; Dermatitis, Atopic; Dermis; Female; Fluorescent Antibody Technique; Humans; Male; Middle Aged; Prurigo; Pruritus; Sensory Receptor Cells; Substance P

2010
Calcitonin gene-related peptide immunoreactivity in prurigo nodularis: a comparative study with neurodermatitis circumscripta.
    The British journal of dermatology, 1989, Volume: 120, Issue:5

    Topics: Calcitonin; Calcitonin Gene-Related Peptide; Female; Fluorescent Antibody Technique; Humans; Hyperplasia; Male; Neurodermatitis; Neurons; Neuropeptides; Prurigo; Skin; Substance P

1989